keyword
https://read.qxmd.com/read/38539861/lercanidipine-s-antioxidative-effect-prevents-noise-induced-hearing-loss
#1
JOURNAL ARTICLE
Zhaoqi Guo, E Tian, Sen Chen, Jun Wang, Jingyu Chen, Weijia Kong, Debbie C Crans, Yisheng Lu, Sulin Zhang
Noise-induced hearing loss (NIHL) is a prevalent form of adult hearing impairment, characterized by oxidative damage to auditory sensory hair cells. Although certain dihydropyridines, the L-type calcium channel blockers, exhibit protective properties against such damage, the ability of third-generation dihydropryidines like lercanidipine to mitigate NIHL remains unclear.We utilized glucose oxidase (GO)-treated OC1 cell lines and cochlear explants to evaluate the protective influence of lercanidipine on hair cells...
March 7, 2024: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/38349603/lercanidipine-ameliorated-doxorubicin-induced-neuroinflammation-and-maintained-the-expressions-of-choline-acetyltransferase-via-enhancing-the-levels-of-pi3k-akt-hif1-%C3%AE-expressions
#2
JOURNAL ARTICLE
Melike Dogan Unlu, Sanem Asci, Halil Asci, Serife Agirca Tasan, Ozlem Ozmen, Rumeysa Taner, Serpil Demirci
BACKGROUND: Doxorubicin (DOX) may cause various neurological side effects in the brain. Lercanidipine (LRD) has antioxidant, anti-inflammatory, and anti-apoptotic properties. The aim of this study was to investigate the potential benefits of. METHODS AND RESULTS: Lercanidipine in reducing doxorubicin-induced neuroinflammation and maintaining the expressions of choline acetyltransferase. Thirty-two adult Wistar albino female rats were divided into four groups as Control, DOX (20 mg/kg intraperitoneally), DOX + LRD 0...
February 13, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38305651/effects-of-lercanidipine-on-traumatic-spinal-cord-injury-an-experimental-study
#3
JOURNAL ARTICLE
Çağlar Türk, Sinan Bahadır, Mahmut Camlar, Çevik Gürel, Aylin Buhur, Gökçe Ceren Kuşçu
BACKGROUND: Spinal cord injury is a devastating trauma that leaves survivors at risk for several medical complications throughout their lives. Lercanidipine, a third-generation calcium channel blocker, possesses anti-apoptotic, anti-inflammatory, and antioxidative properties. This study aimed to evaluate the neuroprotective effects of lercanidipine in an experimental spinal cord trauma model. METHODS: Twenty-one Wistar rats were randomly assigned to three groups...
February 2024: Turkish Journal of Trauma & Emergency Surgery: TJTES
https://read.qxmd.com/read/38236117/melanoma-and-dysplastic-nevi-development-after-ranitidine-rilmenidine-%C3%B0-oxonidine-lercanidipine-rosuvastatin-and-verapamil-trandolapril-new-data-case-series-the-potential-role-of-nitrosamine-ndsris-contamination-in-polymedication-as-substantial-skin-cancer
#4
JOURNAL ARTICLE
G Tchernev, N Naydekova
The idea of drug-induced/exogenic Nitrosogenesis is driven by the possibility of prolonged exposure of the human body to the influence of nitrosamines within the drug intake - substances or contaminants that have been proven to be carcinogenic or mutagenic one.Until recently, there was a complete lack of data in the scientific literature on the relationship between cancer, polymedication and polycontamination with nitrosamines. In the last decade, melanoma has been described repeatedly in the medical literature as a possible side-effect within the intake of possibly with nitrosamines contaminated medications such as: Valsartan, Hydrochlorothiazide, Amlodipine, Nebivolol, Bisoprolol and Perindopril...
November 2023: Georgian Medical News
https://read.qxmd.com/read/37991960/nitrosogenesis-lessons-from-dermatologists-nitrosamines-ndsris-contamination-of-the-polimedication-in-polimorbid-patients-as-the-most-powerful-skin-cancer-inductor-double-hatchet-flap-for-scc-of-the-scalp-occurring-during-treatment-with-valsartan-hydrochlorothiazide
#5
JOURNAL ARTICLE
G Tchernev
Nitrosogenesis remains to be a topic that is and, in all likelihood, will be relevant in the near and distant future. The reason for this actuality is mainly due to the official data of the regulatory authorities in the face of the FDA, starting back in 2018 with the announcement of the contamination of Valsartan with nitrosamines. This issue only became more profound in April 2023, when again the FDA declared over 250 of the most widely distributed drugs worldwide as actually or potentially contaminated with ˝hypothetical˝ carcinogens...
September 2023: Georgian Medical News
https://read.qxmd.com/read/37872105/drug-clustering-to-anticipate-new-aspects-of-drug-safety-profile-application-to-gabapentinoids-and-other-voltage-gated-calcium-channel-ligand-drugs
#6
JOURNAL ARTICLE
Thibault Viguier, Marie-Sara Agier, Annie-Pierre Jonville-Béra, Bruno Giraudeau, Bérenger Largeau
AIM: Gabapentin and pregabalin bind to α2-δ subunit of voltage-gated calcium channels (Cav ). Other drugs targeting Cav include cardiovascular calcium channel blockers (CCBs) and anticonvulsants (levetiracetam, ethosuximide, zonisamide). In addition to pharmacodynamics, the safety profile of gabapentinoids seems to overlap with the one of cardiovascular CCBs (edema) and Cav -blocking anticonvulsants (suicide, ataxia). The objective of this study was to cluster the safety profile of different Cav -ligand drugs by focusing on whether gabapentinoids present a distinct adverse drug reactions (ADR) signature from cardiovascular CCBs and anticonvulsants...
October 23, 2023: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/37796461/-lercanidipine-distribution-in-warm-blooded-animals
#7
JOURNAL ARTICLE
L L Kvachakhiya, V K Shormanov
Is to investigate the lercadipine distribution in warm-blooded animals (rats). The experimental study used rats of Wistar race. TLC, GC-MS and UV-spectrophotometry methods were used for physical and chemical analysis. Semilethal (890 mg/kg) dose of lercadipine, previously suspended in water, was injected into stomach of laboratory animals. Examined substance was isolated from the thick tissues and animals' blood by acetone, cleaned with a change of solvent and macrocolumn chromatography using 30 µm «Silasorb S-18» sorbent and acetonitrile-water (8:2) polar eluent...
2023: Sudebno-meditsinskaia Ekspertiza
https://read.qxmd.com/read/37762350/new-insights-into-the-nephroprotective-potential-of-lercanidipine
#8
REVIEW
Joanna Hajdys, Piotr Fularski, Klaudia Leszto, Gabriela Majchrowicz, Magdalena Stabrawa, Ewelina Młynarska, Jacek Rysz, Beata Franczyk
Kidneys are responsible for many crucial biological processes in the human body, including maintaining the water-electrolyte balance, pH, and blood pressure (BP), along with the elimination of toxins. Despite this, chronic kidney disease (CKD), which affects more and more people, is a disease that develops insidiously without causing any symptoms at first. The main purpose of this article is to summarize the existing literature on lercanidipine, with a particular focus on its nephroprotective properties. Lercanidipine is a third-generation dihydropyridine (DHP) blocker of calcium channels, and as such it possesses unique qualities such as high lipophilicity and high vascular selectivity...
September 13, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37672098/lercanidipine-alleviates-doxorubicin-induced-lung-injury-by-regulating-perk-chop-and-bax-bcl-2-cyt-c-pathways
#9
JOURNAL ARTICLE
Muhammet Yusuf Tepebaşı, Jale Selli, Salih Gül, İbrahim Hüseynov, Adem Milletsever, Esma Selçuk
Doxorubicin (DOX), which is used to treat various cancers and hematological malignancies, has limited therapeutic application due to its toxicity in tissues and organs. These toxic effects occur through alterations in intracellular calcium regulation, elevated cell stress and oxidative damage, and increased apoptosis. Lercanidipine (LRD) is a long-acting antihypertensive calcium channel blocker with anti-inflammatory, anti-apoptotic, and antioxidant effects. The aim of this study was to investigate the effect of LRD on DOX-induced lung toxicity...
September 6, 2023: Histochemistry and Cell Biology
https://read.qxmd.com/read/37648584/renin-angiotensin-aldosterone-system-inhibitors-and-mortality-risk-in-elderly-patients-with-atrial-fibrillation-insights-from-the-nationwide-start-registry
#10
JOURNAL ARTICLE
Danilo Menichelli, Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Pasquale Pignatelli, Daniele Pastori
BACKGROUND: Arterial hypertension is the most common cardiovascular comorbidity in atrial fibrillation (AF). Few studies investigated management strategies of hypertension in AF. MATERIALS AND METHODS: We included 5769 AF patients on oral anticoagulants from the nationwide ongoing Italian START registry. We investigated the prescription of antihypertensive drugs and mortality risk. Subgroup analyses according to sex and major cardiovascular comorbidities were performed...
August 28, 2023: European Journal of Internal Medicine
https://read.qxmd.com/read/37588227/the-link-between-intracellular-calcium-signaling-and-exosomal-pd-l1-in-cancer-progression-and-immunotherapy
#11
REVIEW
Md Rakibul Alam, Md Mizanur Rahman, Zhiguo Li
Exosomes are small membrane vesicles containing microRNA, RNA, DNA fragments, and proteins that are transferred from donor cells to recipient cells. Tumor cells release exosomes to reprogram the factors associated with the tumor microenvironment (TME) causing tumor metastasis and immune escape. Emerging evidence revealed that cancer cell-derived exosomes carry immune inhibitory molecule program death ligand 1 (PD-L1) that binds with receptor program death protein 1 (PD-1) and promote tumor progression by escaping immune response...
January 2024: Genes & Diseases
https://read.qxmd.com/read/37284897/investigation-of-cardioprotective-effect-of-lercanidipine-on-doxorubicin-induced-cardiotoxicity
#12
JOURNAL ARTICLE
Nasif Fatih Karakuyu, Mehtap Savran, Ibrahim Aydin Candan, Halil Ibrahim Buyukbayram, Yalcin Erzurumlu
Although doxorubicin (DOX) is an effective anti-neoplastic drug for many types of cancer, particularly dose-related cardiotoxicity limits the use of the drug. In this study, it was aimed to investigate the protective effect of lercanidipine (LRD) against DOX-induced cardiotoxicity. In our study, 40 Wistar albino female rats were randomly divided into 5 groups as control, DOX, LRD 0.5 (DOX + 0.5 mg/kg LRD), LRD 1 (DOX + 1 mg/kg LRD), and LRD 2 (DOX + 2 mg/kg LRD)...
June 7, 2023: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/37236776/evaluation-of-drug-interaction-between-cyclosporine-and-lercanidipine-a-descriptive-study
#13
JOURNAL ARTICLE
Kamer Tecen-Yucel, Aygin Bayraktar-Ekincioglu, Tolga Yıldırım, Kutay Demirkan, Yunus Erdem
OBJECTIVES: Cyclosporine is an immunosuppressive drug with a high potential for drug interactions that is frequently used in renal transplant patients. The purpose of this study was to assess the change in cyclosporine concentration in patients taking cyclosporine and lercanidipine concurrently. METHODS: The potential drug interactions in renal transplant patients who received lercanidipine and cyclosporine concurrently in a university hospital between January 2008 and January 2018 were evaluated retrospectively...
May 26, 2023: European Journal of Hospital Pharmacy. Science and Practice
https://read.qxmd.com/read/37114573/-not-available
#14
REVIEW
Birgit K Skovbjerg, Ole Kl Helgestad, Christina S Oxlund, Bo Christensen, Jakob N Henriksen
Pedal oedema is a well-known adverse effect of amlodipine, but significantly less frequent if only half of the maximum recommended dosage is used. Diuretics are ineffective. To cause as few side effects as possible, options for managing are prioritised in this review: Reduce dosage, switch to lercanidipine/lacidipine, switch to another group, add/increase dosage of an ACE-inhibitor/angiotensin II-receptor blocker, administer at night, or switch to verapamil/diltiazem. Non-pharmacologic actions or observation may be considered when the oedemas are mild and not bothersome...
April 17, 2023: Ugeskrift for Laeger
https://read.qxmd.com/read/36929845/comprehensive-and-validated-chromatographic-techniques-for-the-estimation-of-lercanidipine-hydrochloride-and-atenolol-in-bulk-and-combined-dosage-form-in-the-presence-of-lercanidipine-degradation-products-with-lc-ms-characterization
#15
JOURNAL ARTICLE
Shereen A Boltia, Taghreed A Fattah, Marwa T Saad, Hala E Zaazaa
Two rapid, smart and validated stability indicating HPLC and TLC techniques were developed to determine atenolol (ATE) and lercanidipine HCl (LER) simultaneously in their pharmaceutical formulation. HPLC chromatographic separation was implemented by using Microsorb C18 (250 × 4.6 mm, 5 μm) column, with mobile phase of acetonitrile and 20 mM potassium dihydrogen phosphate buffer pH 3.5 adjusted by orthophosphoric acid in the ratio of (65:35, v/v) at a flow rate of 1...
March 17, 2023: Journal of Chromatographic Science
https://read.qxmd.com/read/36902718/chyloperitoneum-in-peritoneal-dialysis-secondary-to-calcium-channel-blocker-use-case-series-and-literature-review
#16
Luca Piscitani, Gianpaolo Reboldi, Angelo Venanzi, Francesca Timio, Annamaria D'Ostilio, Vittorio Sirolli, Mario Bonomini
Chyloperitoneum (chylous ascites) is a rare complication of peritoneal dialysis (PD). Its causes may be traumatic and nontraumatic, associated with neoplastic disease, autoimmune disease, retroperitoneal fibrosis, or rarely calcium antagonist use. We describe six cases of chyloperitoneum occurring in patients on PD as a sequel to calcium channel blocker use. The dialysis modality was automated PD (two patients) and continuous ambulatory PD (the rest of the patients). The duration of PD ranged from a few days to 8 years...
March 1, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/36480125/a-design-assisted-spectrofluorometric-method-utilizing-a-one-pot-fluorescent-probe-for-the-quantitation-of-some-calcium-channel-blockers
#17
JOURNAL ARTICLE
Aya Roshdy, Randa Abdel Salam, Ghada Hadad, Fathallah Belal, Heba Elmansi
Based on their reaction with highly fluorescent carbon quantum dots (CQDts), a precise and reliable spectrofluorometric approach was developed for the determination of three calcium channel blockers. The studied drugs are: lercanidipine, nimodipine and nifedipine. (CQDts) were produced using a one-step hydrothermal method with ascorbic acid as the carbon source. The produced CQDts were capped by alcohol to create yellow emitters displaying a high fluorescence emission at 524 nm when excited at 325 nm...
December 8, 2022: Journal of Fluorescence
https://read.qxmd.com/read/36459001/author-correction-antihypertensive-treatment-with-calcium-channel-blockers-and-renal-protection-focus-on-lercanidipine-and-lercanidipine-enalapril
#18
JOURNAL ARTICLE
N Ferri, A Corsini, R Pontremoli
Correction to: European Review for Medical and Pharmacological Sciences 2022; 26 (20): 7482-7492. DOI: 10.26355/eurrev_202210_30018-PMID: 36314318, published online on October 28, 2022. After publication, the authors applied some corrections to the text: - The section "Clinical Oharmacology of Lercanidipine" has been corrected into "Clinical Pharmacology of Lercanidipine" - The Legend of Figure 2 has been corrected as follows: Ca T-type channels vs. Ca L-type channels selectivity ratio. LAC, lacidipine, AML, amlodipine; MIB, mibefradil; LER, lercanidipine; *p<0...
November 2022: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/36314318/antihypertensive-treatment-with-calcium-channel-blockers-and-renal-protection-focus-on-lercanidipine-and-lercanidipine-enalapril
#19
REVIEW
N Ferri, A Corsini, R Pontremoli
OBJECTIVE: The aim of the study was to review the literature on clinical pharmacology of lercanidipine and experimental and clinical evidence and evaluate its ability to reduce proteinuria and preserve renal function when used as monotherapy or in combination with the angiotensin-converting enzyme (ACE) inhibitor enalapril. MATERIALS AND METHODS: MEDLINE/PubMed was searched for appropriate keywords. RESULTS: Lercanidipine, a third-generation calcium channel blocker, has been shown to have a unique pharmacological and clinical profile, which translates into favorable renal hemodynamic changes...
October 2022: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/36027190/cost-effectiveness-of-polypill-treatment-in-high-risk-hypertensive-subjects-with-hyper-cholesterolaemia
#20
JOURNAL ARTICLE
Alberto Mazza, Gianni Bregola, Enrico Cavazzin, Fabio Dell'avvocata, Massimo Giordan, Gianluca Rigatelli, Marinella Rosini, Bruno Bignardi, Antonio Bragiotto, Tiziano Crino, Gabriella Chieregato, Roberto Fante, Mauro Favaron, Matteo Lazzarin, Ettore Petracca, Michele Roccato, Silvia Sartorello, Giovanni Scanavacca, Maria Lucia Zaramella, Stefano Cuppini
OBJECTIVE: Hypertension and hyper-cholesterolaemia is a dangerous combination frequently found in clinical practice. Despite a wide range of medications available for these both conditions, a large proportion of treated patients remain uncontrolled. We aimed to evaluate the cost-effectiveness treatment of a polypill in high-risk hypertensive and hyper-cholesterolemic subjects. DESIGN AND METHOD: 46 subjects (mean age 67.4 ± 11.5 years, 69.6% men) treated a with free-combination (FCT) of statins (atorvastatin 63...
June 1, 2022: Journal of Hypertension
keyword
keyword
54850
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.